Search - tctmd.com

Displaying 861 - 880 of 988

Sort: Relevancy | Date

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Conference News

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Industry News

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

November 08, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Conference News

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

November 07, 2011

News Daily News

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

November 06, 2011

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

Advertisement

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Paclitaxel-coated balloon angioplasty demonstrates superior results

RAPID GENE: Validation of Point-of-Care Genetic Testing

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Low CV Event Rate Prompts Closure of Prasugrel Trial

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

ZES and SES Equally Effective in Long Lesion Treatment

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content